MedTrace Logo

The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol

NCT00620646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-02-12

No results posted yet for this study

Summary

To compare the effect of increased dosing of clopidogrel and adding cilostazol to standard dose of clopidogrel after the insertion of drug-eluting stent in patients with clopidogrel resistance

Conditions

  • Clopidogrel Non-Responsiveness

Interventions

DRUG

aspirin, clopidogrel

aspirin 100 mg plus clopidogrel 150mg qd

DRUG

aspirin, clopidogrel, cilostazol

aspirin 100mg qd,clopidogrel 75mg qd plus cilostazol 100mg bid

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hyeon-Cheol Gwon, MD, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-12-31
Completion
2009-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620646 on ClinicalTrials.gov